2012 annual financial data
Tenax Therapeutics 2012 Operating margin
Direct answer
Operating margin was -5,844.34%.
Operating income was -16,874,115 USD and net income was -19,541,839 USD.
Operating cash flow was -4,921,283 USD.
Get free Tenax Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 288,726 USD
- Operating income
- -16,874,115 USD
- Net income
- -19,541,839 USD
- Operating cash flow
- -4,921,283 USD